School of Medicine


Showing 4,601-4,620 of 5,182 Results

  • Larry W. Thompson, Ph.D.

    Larry W. Thompson, Ph.D.

    Professor (Research) of Medicine (Endocrinology, Gerontology, and Metabolism), Emeritus

    Current Research and Scholarly InterestsDr. Thompson’s interests include psychosocial treatments for individuals with bipolar disorder and /or other serious mental illnesses; cognitive/behavioral therapy for late-life depression; intervention research with culturally diverse individuals with depression; and psychophysiological research on stress & coping.

  • Alan Eih Chih Thong

    Alan Eih Chih Thong

    Clinical Associate Professor, Urology

    BioDr. Thong is a surgeon specializing in urologic oncology. He has expertise in all aspects of prostate, kidney, bladder, and testicular cancer care, including endoscopic, robotic, and open surgery, and has a special interest in complex cases including: salvage surgery following radiation or chemotherapy, resection of locally advanced tumors, minimal access robotic surgery, and MRI-US fusion targeted biopsies. Dr. Thong is the first surgeon in northern California to utilize single port robotic assisted laparoscopic technology for both pelvic and retroperitoneal surgeries. He has won numerous awards including the NIH Ruth L. Kirschstein National Research Service Award, and has authored and co-authored publications on the treatment of urologic cancers.

  • Zachary D. Threlkeld, MD, FAAN

    Zachary D. Threlkeld, MD, FAAN

    Clinical Associate Professor, Adult Neurology
    Clinical Associate Professor (By courtesy), Neurosurgery

    BioDr. Threlkeld cares for critically ill patients with acute neurologic illness, including traumatic brain injury, stroke, intracerebral hemorrhage, and epilepsy. He completed his residency training in neurology at the University of California, San Francisco, and joined the Stanford Neurocritical Care program after completing fellowship training in neurocritical care at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston. He has a clinical and research interest in traumatic brain injury and disorders of consciousness. In addition, he maintains a strong interest in improvement science, quality improvement, and patient safety.

  • Lu Tian

    Lu Tian

    Professor of Biomedical Data Science and, by courtesy, of Statistics

    Current Research and Scholarly InterestsMy research interest includes
    (1) Survival Analysis and Semiparametric Modeling;
    (2) Resampling Method ;
    (3) Meta Analysis ;
    (4) High Dimensional Data Analysis;
    (5) Precision Medicine for Disease Diagnosis, Prognosis and Treatment.

  • Robert Tibshirani

    Robert Tibshirani

    Professor of Biomedical Data Science and of Statistics

    Current Research and Scholarly InterestsMy research is in applied statistics and biostatistics. I specialize in computer-intensive methods for regression and classification, bootstrap, cross-validation and statistical inference, and signal and image analysis for medical diagnosis.

  • Seda Tierney

    Seda Tierney

    Professor of Pediatrics (Cardiology)

    Current Research and Scholarly InterestsAssessment of vascular health in children by non-invasive modalities

    Exercise interventions in children with congenital and acquired heart disease

    Use of telehealth to deliver interventions to children with congenital and acquired heart disease

    Parentally-acquired echocardiograms

    Quality Improvement in Pediatric Echocardiography

    Echocardiography and outcomes in congenital heart disease

  • Hemali Vijay Panchal

    Hemali Vijay Panchal

    Clinical Assistant Professor, Medicine

    Current Research and Scholarly InterestsQuality Improvement, Patient Safety, Medical Education

  • Alice Ting

    Alice Ting

    Professor of Genetics, of Biology and, by courtesy, of Chemistry

    Current Research and Scholarly InterestsWe develop chemogenetic and optogenetic technologies for probing and manipulating protein networks, cellular RNA, and the function of mitochondria and the mammalian brain. Our technologies draw from protein engineering, directed evolution, computational design, chemical biology, organic synthesis, microscopy, and genomics.

  • Daniel SW Ting

    Daniel SW Ting

    Adjunct Clinical Associate Professor, Ophthalmology

    BioDaniel Ting, MD, PhD, Stanford Adjunct Associate Professor and Duke-NUS Jong Soy Leong Professor, is one of the world's leading clinician-AI scientists, vitreoretinal surgeons, technology innovators and entrepreneurs, with expertise spanning retinal medicine and surgery, AI and healthcare technology. His work sits at the intersection of medicine, AI, innovation and technology translation. A former US-ASEAN Fulbright Scholar at the Johns Hopkins University Applied Physics Laboratory and School of Medicine, his research spans machine learning, deep learning, large language models, multimodal foundation models, explainable AI and privacy-preserving technologies, alongside safe, responsible and ethical clinical AI. He has contributed to international consensus and reporting initiatives including STARD-AI, QUADAS-AI and DECIDE-AI.

    Professor Ting works across the full translational spectrum of AI in healthcare, from algorithm development and multimodal foundation models to generative and agentic AI, clinical implementation, regulatory science, health economics and commercialization. He is Founding Co-Director of the SingHealth Duke-NUS Artificial Intelligence in Medicine Institute (AIMI), Director of the SingHealth AI Office, Chief Data & Digital Officer of the Singapore National Eye Centre, and Head of AI & Digital Innovation at the Singapore Eye Research Institute. He serves on Singapore's Ministry of Health AI Steering Committee and is a core leader of SIMFONI, Singapore's national programme for sovereign multimodal foundation models in healthcare.

    His research has advanced the development, validation and real-world deployment of medical AI, including national-scale AI-enabled diabetic retinopathy screening, health-economic evaluation, privacy-preserving AI, medical imaging foundation models and responsible generative AI. More recently, his work has expanded into sovereign agentic AI and enterprise AI orchestration, combining frontier models, specialised agents, institutional knowledge, verification and structured human oversight for regulated environments.

    Professor Ting has authored more than 400 peer-reviewed publications, attracting more than 45,000 citations with an H-index above 86, including influential work in JAMA, The Lancet, Nature Medicine, Nature Biomedical Engineering, The Lancet Digital Health and NEJM AI. He was recognised in the World's Top 100 AI Power List (2024) alongside AI leaders including Jensen Huang, Fei-Fei Li and Yann LeCun. He has been named among Stanford University's World's Top 2% Scientists (2022–2026), the Top 100 Power List in Ophthalmology, and the World's Top 10 Ophthalmic Innovators (2025). Major honours include Singapore's Young Scientist Award, National Clinician Scientist Award, APAO Nakajima Award, APVRS Ian Constable Award, ARVO Bert Glaser Award and Macula Society Evangelos Gragoudas Award.

    Professor Ting serves on the International Advisory Board of The Lancet Digital Health, is Section Editor for AI at the British Journal of Ophthalmology, and holds editorial leadership roles with Ophthalmology, Ophthalmology Retina and Ophthalmology Science. He also holds international leadership positions across the American Academy of Ophthalmology and major Asia-Pacific ophthalmology and vitreoretinal societies.

    Beyond academia, Professor Ting is a serial inventor, start-up founder and technology entrepreneur, co-founding ventures spanning medical AI, ophthalmology, healthy longevity and sovereign agentic AI. His work bridges Stanford and Silicon Valley's frontier AI and innovation ecosystem with Singapore's integrated healthcare and national AI infrastructure, translating frontier AI into trusted and scalable technologies. His mission is to build the next generation of trusted, sovereign and clinically intelligent AI systems, moving healthcare AI from algorithms to infrastructure, from prediction to reasoning, and from scientific discovery to global-scale impact.

  • Jamie L. Tingey, PhD

    Jamie L. Tingey, PhD

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine

    Current Research and Scholarly InterestsDr. Tingey’s research broadly focuses on factors that promote positive outcomes in patients with complex and/or chronic conditions. She is committed to research that focuses on outcomes that are valued by patients and healthcare stakeholders.

    Some of her research interests include self-management interventions in chronic conditions (e.g., multiple sclerosis, stroke, spinal cord injury, traumatic brain injury) and adapting evidence-based treatments to provide equitable care to individuals with chronic conditions and disabilities. She is also passionate about integrating psychology services into critical care settings to improve health outcomes among ICU survivors.

  • Julie Tinklenberg

    Julie Tinklenberg

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Vaden Health Center

    BioDr. Julie Tinklenberg specializes in the treatment of mental illness in the university setting. She has worked in college mental health for over 15 years. Dr.Tinklenberg has a special interest in anxiety disorders, parenting issues, mood disorders and interpersonal/relationship problems.

  • Jyothi Tirumalasetty, MD, FAAAAI

    Jyothi Tirumalasetty, MD, FAAAAI

    Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine

    Current Research and Scholarly InterestsReducing healthcare-related carbon emissions with a focus on inhalers.
    Health disparities in food allergy.
    Climate change and asthma.

  • Rebecca Lauren Tisdale

    Rebecca Lauren Tisdale

    Assistant Professor of Medicine (PCPH)

    BioBecca Tisdale, MD, MPA is an internist, obesity medicine specialist, and health services researcher with interests in cardiovascular disease, global health, and health systems. As a VA Health Services Research & Development fellow (2020-2023) and Investigator in the VA Center for Innovation to Implementation (Ci2i) and Stanford Cardiovascular Outcomes, Policy, & Implementation Research Group (COPIR), her work has focused on value, access, and equity in cardiovascular disease care and the role of virtual care in achieving these goals. She additionally serves as Medical Director of the Evaluation Sciences Unit (ESU) with the Division of Primary Care and Population Health.

    Previously, she received a BA with distinction in Human Biology from Stanford in 2009, followed by a master of public administration (MPA) joint degree from Sciences Po, Paris and the London School of Economics. She then matriculated at Columbia University College of Physicians and Surgeons for medical school, where she was active in global health activities, researching multidisciplinary teams in HIV care in Ethiopia and serving on the board of the student international health organization. As a global health track resident at Stanford, Becca spent time working in Rwanda through the Johnson and Johnson program and participated in the inaugural Women Leaders in Global Health conferences at Stanford and in London. In 2019-2020, she comprised one third of Stanford’s first all-woman internal medicine chief resident cohort. Outside of work, she enjoys all things French as well as running, both in races and after her young children.

  • Christina (Christy) Tise, MD, PhD

    Christina (Christy) Tise, MD, PhD

    Assistant Professor of Pediatrics (Genetics) and, by courtesy, of Obstetrics & Gynecology (Reproductive Endocrinology and Infertility)

    BioDr. Christina (Christy) Tise is a physician scientist and Assistant Professor in the Division of Medical Genetics at Stanford with subspecialty training in Clinical Biochemical Genetics. Dr. Tise has developed multiple research projects focused on the clinical impact of biochemical genetic conditions in pregnancy and newborn health, including a project focused on unforeseen diagnoses in individuals initially identified through state newborn screening which has resulted in a number of publications.

    Dr. Tise also researches the genetic etiologies of recurrent pregnancy loss and the impact of inherited metabolic conditions on human reproduction. She is involved in several research initiatives including contributing to the development of TRIOS, a multi-site, NIH-funded research study to evaluate the genetic causes of recurrent pregnancy loss. In serving as the primary research mentor for a recent Masters of Genetic Counseling graduate, Dr. Tise’s research on carrier and newborn screening has highlighted areas of ancestry-related healthcare inequities specific to the field of Medical Genetics.

    Dr. Tise’s primary academic and advocacy interests are embodied in this work, specifically the overlap between biochemical and molecular analysis, and the clinical utility of innovative technologies for diagnosis and treatment of genetic disease. This is an unbelievably thrilling time for the field of Medical Genetics, as it promises immense progress and opportunity for all fields of medicine, and Dr. Tise is determined, honored, and incredibly excited to be a part of it!

    Research interests: newborn screening, carrier screening, prenatal screening, genetics of recurrent pregnancy loss, biochemical genetics, novel gene discovery, variant interpretation, founder populations, diagnostic genetic testing, bioethics, GWAS/ExWAS